vTv Therapeutics News

VTv Therapeutics Q1 EPS $(1.17) Up From $(2.40) YoY, Sales $1.00M

vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(1.17) per share. This is a 51.25 percent increase over losses of $(2.40) per share from the same period last year. The company reported $

BenzingaMay 10 06:08

VTv Therapeutics 1Q Rev $1M >VTVT

VTv Therapeutics 1Q Rev $1M >VTVT

Dow JonesMay 10 04:51

VTv Therapeutics 1Q Loss/Shr $1.17 >VTVT

VTv Therapeutics 1Q Loss/Shr $1.17 >VTVT

Dow JonesMay 10 04:51

Press Release: VTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update

vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update HIGH POINT, N.C., May 09, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage

Dow JonesMay 10 04:51

vTv Therapeutics | 10-Q: Quarterly report

Futu NewsMay 10 04:42 · Announcements

VTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update

PDF Version HIGH POINT, N.C., May 09, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of an adjunctive therapy

vTv TherapeuticsMay 9 12:00

VTv Therapeutics Files $250M Mixed Securities Shelf

Seeking AlphaApr 11 05:19

CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT

Podium presentation will include clinical updates from the Company's Phase 2 clinical trials investigating azeliragon, in combination with radiation therapy with or without temozolomide, in newly dia

PR NewswireMar 19 20:30

VTv Therapeutics Appoints Anne Phillips, Reshuffles Board Committees

TipRanksMar 14 20:12

VTv Therapeutics Q4 EPS $(1.67) Up From $(2.28) YoY

vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(1.67) per share. This is a 26.75 percent increase over losses of $(2.28) per share from the same period last year.

BenzingaMar 13 20:03

Press Release: VTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update

vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update -- Recently completed $51 million PIPE from healthcare-focused institutional inve

Dow JonesMar 13 20:00

VTv Therapeutics 4Q Loss/Shr $1.67 >VTVT

VTv Therapeutics 4Q Loss/Shr $1.67 >VTVT

Dow JonesMar 13 20:00

VTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update

PDF Version Recently completed $51 million PIPE from healthcare-focused institutional investors and the JDRF T1D Fund. Company's first Phase 3 clinical trial of cadisegliatin (TTP399), an oral adju

vTv TherapeuticsMar 13 12:00

12 Health Care Stocks Moving In Tuesday's After-Market Session

GainersNKGen Biotech (NASDAQ:NKGN) stock increased by 62.4% to $1.4 during Tuesday's after-market session. The company's market cap stands at $30.6 million. vTv Therapeutics (NASDAQ:VTVT) stock moved

BenzingaMar 6 05:31

VTv Therapeutics Enhances Investor Communication With Update

TipRanksMar 5 21:23

VTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients With Type 1 Diabetes

PDF Version HIGH POINT, N.C., March 04, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin (TTP3

vTv TherapeuticsMar 4 13:00

VTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference

PDF Version HIGH POINT, N.C., March 01, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin (TTP3

vTv TherapeuticsMar 1 13:00

Top Midday Gainers

Vivani Medical's (VANI) shares quadrupled after the company announced positive preclinical data on its NPM-115 implant for weight loss, comparable to Novo Nordisk's Ozempic and Wegovy. More than 126.8

MT NewswiresFeb 29 03:22

Trending Stocks Today: Vivani Medical Surges 329.84%

February 28th - US stocks trending in regular trading hours.Gainers: $Vivani Medical(VANI.US)$ soars 329.84% to $4.34 with a turnover of $534.17 million. $Adial Pharmaceuticals(ADIL.US)$ shoots up 130

Futu NewsFeb 29 03:00

12 Health Care Stocks Moving In Wednesday's Intraday Session

GainersVivani Medical (NASDAQ:VANI) stock increased by 314.4% to $4.19 during Wednesday's regular session. The company's market cap stands at $213.5 million. Adial Pharmaceuticals (NASDAQ:ADIL) stock

BenzingaFeb 29 01:31